Targeting PCSK9 as a promising new mechanism for lowering low-density lipoprotein cholesterol

Title
Targeting PCSK9 as a promising new mechanism for lowering low-density lipoprotein cholesterol
Authors
Keywords
PCSK9, Cardiovascular disease, Low-density lipoprotein cholesterol, Hypercholesterolemia, Alirocumab, Evolocumab
Journal
PHARMACOLOGY & THERAPEUTICS
Volume 164, Issue -, Pages 183-194
Publisher
Elsevier BV
Online
2016-04-30
DOI
10.1016/j.pharmthera.2016.04.011

Ask authors/readers for more resources

Reprint

Contact the author

Find the ideal target journal for your manuscript

Explore over 38,000 international journals covering a vast array of academic fields.

Search

Become a Peeref-certified reviewer

The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.

Get Started